REFERENCES
- Marrie TJ. Pneumonia in the elderly. Curr Opin Pulm Med 1996; 2: 192–197.
- Woodhead MA, Arrowsmith J, Chamberlain-Webber R, Wooding S, Williams I. The value of routine microbial investigation in community acquired pneumonia. Respir Med 1991; 85: 313–317.
- Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134–141.
- American Thoracic Society. Guidelines for the initial management of adults with community acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418–1426.
- Mandell LA, Niederman MS. The Canadian Community Acquired Pneumonia Consensus Group. Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Can J Infect Dis 1993; 4: 25–28.
- Gialdroni Grassi G, Bianchi L. Guidelines for the management of community acquired pneumonia in adults. Monaldi Arch Chest Dis 1995; 50: 21–27.
- Col NF, 0' Connor RW. Estimating worldwide current antibiotic usage: report of Task Force. Rev Infect Dis 1987; 9 (Suppl. 3):5232-5243.
- de Latta F. Antimicrobial agents rationale and monitoring in an Italian hospital. J Chemother 1996; 5: 342–350.
- Marr JJ, Moffer HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988; 157: 869–876.
- Coleman R, Rodond L, Kaubisch S et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987-1989. Am J Med 1991; 90: 439–444.
- Fletcher CV, Metzler D, Borchardt-Phelps P, Rodman JH. Patterns of antibiotics use and expenditures during 7 years at a university hospital. Pharmacotherapy 1990; 10 (3): 199–204.
- Guglielmo L, Leone R, Moretti U, Conforti A, Spolaor A, Velo G. Antibiotic prescribing patterns in Italian hospital inpatients with pneumonia, chronic obstructive pulmonary disease, and urinary tract infections. Ann Pharmacother 1993; 27: 18–22.
- Davey PG, Malek MM, Sharon EP. Pharma-coeconomics of antibacterial treatment. PharmacoEconomics 1992; 6: 410–436.
- Rush DR. Antimicrobial formulary management: meeting the challenge in the community hospital. Pharmaco-therapy 1991; 11: 19–26.
- Niederman MS. Empirical therapy of community acquired pneumonia. Semin Respir Infect 1994; 9: 192–198.
- Coleman R, Rodond L, Kaubisch S et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987-1989. Am J Med 1991; 90: 439–444.
- Crowe HM, Quintiliani R. Antibiotic formulary selection. Med Clin North Am 1995; 79: 463–476.
- Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991; 90: 439–444.
- Guglielmo BJ, Brooks CF. Antimicrobial therapy. Cost-benefit consideration. Drugs 1989; 38: 473–480.
- Plumridge RJ. Cost comparison of intravenous antibiotic administration. Med J Austr 1990; 153 (5): 516–518.